nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.509	0.691	CbGbCtD
Pentamidine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.227	0.309	CbGbCtD
Pentamidine—S100B—peripheral nervous system—amyotrophic lateral sclerosis	0.0126	0.227	CbGeAlD
Pentamidine—S100B—nerve—amyotrophic lateral sclerosis	0.00985	0.177	CbGeAlD
Pentamidine—Nephritis—Riluzole—amyotrophic lateral sclerosis	0.00834	0.0423	CcSEcCtD
Pentamidine—S100B—hindbrain—amyotrophic lateral sclerosis	0.00738	0.133	CbGeAlD
Pentamidine—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00573	0.029	CcSEcCtD
Pentamidine—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0275	CcSEcCtD
Pentamidine—AOC1—embryo—amyotrophic lateral sclerosis	0.00529	0.0952	CbGeAlD
Pentamidine—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00508	0.0258	CcSEcCtD
Pentamidine—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00508	0.0258	CcSEcCtD
Pentamidine—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.0049	0.0248	CcSEcCtD
Pentamidine—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00463	0.0235	CcSEcCtD
Pentamidine—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0227	CcSEcCtD
Pentamidine—S100B—brainstem—amyotrophic lateral sclerosis	0.00423	0.076	CbGeAlD
Pentamidine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00418	0.0212	CcSEcCtD
Pentamidine—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00414	0.021	CcSEcCtD
Pentamidine—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0204	CcSEcCtD
Pentamidine—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0204	CcSEcCtD
Pentamidine—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0204	CcSEcCtD
Pentamidine—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00395	0.02	CcSEcCtD
Pentamidine—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00385	0.0195	CcSEcCtD
Pentamidine—Abscess—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0183	CcSEcCtD
Pentamidine—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.0178	CcSEcCtD
Pentamidine—Gout—Riluzole—amyotrophic lateral sclerosis	0.00305	0.0155	CcSEcCtD
Pentamidine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00292	0.0148	CcSEcCtD
Pentamidine—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0144	CcSEcCtD
Pentamidine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00278	0.0141	CcSEcCtD
Pentamidine—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00272	0.0138	CcSEcCtD
Pentamidine—S100B—spinal cord—amyotrophic lateral sclerosis	0.00263	0.0473	CbGeAlD
Pentamidine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0125	CcSEcCtD
Pentamidine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0122	CcSEcCtD
Pentamidine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00238	0.0121	CcSEcCtD
Pentamidine—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00237	0.012	CcSEcCtD
Pentamidine—S100B—nervous system—amyotrophic lateral sclerosis	0.00222	0.0398	CbGeAlD
Pentamidine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0022	0.0112	CcSEcCtD
Pentamidine—S100B—central nervous system—amyotrophic lateral sclerosis	0.00213	0.0384	CbGeAlD
Pentamidine—S100B—cerebellum—amyotrophic lateral sclerosis	0.00208	0.0375	CbGeAlD
Pentamidine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0103	CcSEcCtD
Pentamidine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0102	CcSEcCtD
Pentamidine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.002	0.0101	CcSEcCtD
Pentamidine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00993	CcSEcCtD
Pentamidine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00968	CcSEcCtD
Pentamidine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00928	CcSEcCtD
Pentamidine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00906	CcSEcCtD
Pentamidine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00906	CcSEcCtD
Pentamidine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00888	CcSEcCtD
Pentamidine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00871	CcSEcCtD
Pentamidine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0086	CcSEcCtD
Pentamidine—S100B—brain—amyotrophic lateral sclerosis	0.00169	0.0305	CbGeAlD
Pentamidine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00847	CcSEcCtD
Pentamidine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00792	CcSEcCtD
Pentamidine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00787	CcSEcCtD
Pentamidine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0077	CcSEcCtD
Pentamidine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00758	CcSEcCtD
Pentamidine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00738	CcSEcCtD
Pentamidine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00727	CcSEcCtD
Pentamidine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00725	CcSEcCtD
Pentamidine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00722	CcSEcCtD
Pentamidine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00722	CcSEcCtD
Pentamidine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0072	CcSEcCtD
Pentamidine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00714	CcSEcCtD
Pentamidine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00686	CcSEcCtD
Pentamidine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00651	CcSEcCtD
Pentamidine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00648	CcSEcCtD
Pentamidine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00122	0.0062	CcSEcCtD
Pentamidine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00618	CcSEcCtD
Pentamidine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00613	CcSEcCtD
Pentamidine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00591	CcSEcCtD
Pentamidine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00115	0.0207	CbGeAlD
Pentamidine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00584	CcSEcCtD
Pentamidine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00577	CcSEcCtD
Pentamidine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00567	CcSEcCtD
Pentamidine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00566	CcSEcCtD
Pentamidine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00565	CcSEcCtD
Pentamidine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00558	CcSEcCtD
Pentamidine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00555	CcSEcCtD
Pentamidine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00551	CcSEcCtD
Pentamidine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00547	CcSEcCtD
Pentamidine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00545	CcSEcCtD
Pentamidine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00537	CcSEcCtD
Pentamidine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00537	CcSEcCtD
Pentamidine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00537	CcSEcCtD
Pentamidine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00536	CcSEcCtD
Pentamidine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00531	CcSEcCtD
Pentamidine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00526	CcSEcCtD
Pentamidine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0052	CcSEcCtD
Pentamidine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00515	CcSEcCtD
Pentamidine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00512	CcSEcCtD
Pentamidine—Shock—Riluzole—amyotrophic lateral sclerosis	0.001	0.00507	CcSEcCtD
Pentamidine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000995	0.00504	CcSEcCtD
Pentamidine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00503	CcSEcCtD
Pentamidine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000969	0.00491	CcSEcCtD
Pentamidine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00095	0.00481	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000926	0.00469	CcSEcCtD
Pentamidine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000919	0.00466	CcSEcCtD
Pentamidine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000913	0.00463	CcSEcCtD
Pentamidine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000906	0.00459	CcSEcCtD
Pentamidine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00458	CcSEcCtD
Pentamidine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000895	0.00454	CcSEcCtD
Pentamidine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000884	0.00448	CcSEcCtD
Pentamidine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000876	0.00444	CcSEcCtD
Pentamidine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000869	0.00441	CcSEcCtD
Pentamidine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000869	0.00441	CcSEcCtD
Pentamidine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000838	0.00425	CcSEcCtD
Pentamidine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000831	0.00421	CcSEcCtD
Pentamidine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000808	0.00409	CcSEcCtD
Pentamidine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00407	CcSEcCtD
Pentamidine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00407	CcSEcCtD
Pentamidine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000749	0.0038	CcSEcCtD
Pentamidine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000729	0.0037	CcSEcCtD
Pentamidine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000719	0.00365	CcSEcCtD
Pentamidine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000695	0.00353	CcSEcCtD
Pentamidine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000672	0.00341	CcSEcCtD
Pentamidine—S100B—Nuclear signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.000662	0.0612	CbGpPWpGaD
Pentamidine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00066	0.0119	CbGeAlD
Pentamidine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000646	0.00328	CcSEcCtD
Pentamidine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000641	0.00325	CcSEcCtD
Pentamidine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00064	0.00325	CcSEcCtD
Pentamidine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000637	0.00323	CcSEcCtD
Pentamidine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000604	0.00306	CcSEcCtD
Pentamidine—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000513	0.0474	CbGpPWpGaD
Pentamidine—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000479	0.00861	CbGeAlD
Pentamidine—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000461	0.00829	CbGeAlD
Pentamidine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000396	0.00713	CbGeAlD
Pentamidine—CYP1A1—brain—amyotrophic lateral sclerosis	0.000366	0.00658	CbGeAlD
Pentamidine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000351	0.00632	CbGeAlD
Pentamidine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000346	0.00622	CbGeAlD
Pentamidine—S100B—Nuclear signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000344	0.0318	CbGpPWpGaD
Pentamidine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000338	0.00608	CbGeAlD
Pentamidine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000333	0.00599	CbGeAlD
Pentamidine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000325	0.00585	CbGeAlD
Pentamidine—CYP1A1—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000284	0.0262	CbGpPWpGaD
Pentamidine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000281	0.026	CbGpPWpGaD
Pentamidine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000264	0.00475	CbGeAlD
Pentamidine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—ATF1—amyotrophic lateral sclerosis	0.00025	0.0231	CbGpPWpGaD
Pentamidine—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000232	0.0215	CbGpPWpGaD
Pentamidine—S100B—MyD88 cascade initiated on plasma membrane—ATF1—amyotrophic lateral sclerosis	0.000226	0.0209	CbGpPWpGaD
Pentamidine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—amyotrophic lateral sclerosis	0.000224	0.0207	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.000223	0.0206	CbGpPWpGaD
Pentamidine—S100B—MyD88 dependent cascade initiated on endosome—ATF1—amyotrophic lateral sclerosis	0.00022	0.0203	CbGpPWpGaD
Pentamidine—CYP1A1—Oxidative Stress—GSR—amyotrophic lateral sclerosis	0.000217	0.02	CbGpPWpGaD
Pentamidine—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000214	0.0197	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 9 (TLR9) Cascade—ATF1—amyotrophic lateral sclerosis	0.000212	0.0196	CbGpPWpGaD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—ATF1—amyotrophic lateral sclerosis	0.000209	0.0193	CbGpPWpGaD
Pentamidine—S100B—MyD88-independent cascade—ATF1—amyotrophic lateral sclerosis	0.0002	0.0185	CbGpPWpGaD
Pentamidine—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000181	0.0167	CbGpPWpGaD
Pentamidine—S100B—Activated TLR4 signalling—ATF1—amyotrophic lateral sclerosis	0.00018	0.0166	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—ATF1—amyotrophic lateral sclerosis	0.000169	0.0156	CbGpPWpGaD
Pentamidine—CYP4A11—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000154	0.0142	CbGpPWpGaD
Pentamidine—S100B—Toll-Like Receptors Cascades—ATF1—amyotrophic lateral sclerosis	0.000151	0.0139	CbGpPWpGaD
Pentamidine—CYP4A11—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000147	0.0136	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.000135	0.0125	CbGpPWpGaD
Pentamidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00013	0.012	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000116	0.0107	CbGpPWpGaD
Pentamidine—CYP4A11—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000113	0.0104	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000103	0.00948	CbGpPWpGaD
Pentamidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0001	0.00926	CbGpPWpGaD
Pentamidine—CYP1A1—Oxidative Stress—SOD1—amyotrophic lateral sclerosis	9.8e-05	0.00906	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	9.38e-05	0.00867	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.72e-05	0.00806	CbGpPWpGaD
Pentamidine—CYP4A11—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	8.69e-05	0.00803	CbGpPWpGaD
Pentamidine—CYP4A11—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	8.3e-05	0.00767	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.2e-05	0.00758	CbGpPWpGaD
Pentamidine—S100B—Immune System—KIFAP3—amyotrophic lateral sclerosis	8.06e-05	0.00745	CbGpPWpGaD
Pentamidine—CYP1A1—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	7.43e-05	0.00687	CbGpPWpGaD
Pentamidine—CYP4A11—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	6.79e-05	0.00628	CbGpPWpGaD
Pentamidine—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	6.08e-05	0.00562	CbGpPWpGaD
Pentamidine—CYP4A11—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.96e-05	0.00551	CbGpPWpGaD
Pentamidine—CYP1A1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.84e-05	0.0054	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.62e-05	0.00519	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.59e-05	0.00517	CbGpPWpGaD
Pentamidine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	5.59e-05	0.00517	CbGpPWpGaD
Pentamidine—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.35e-05	0.00495	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.29e-05	0.00488	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—ATF1—amyotrophic lateral sclerosis	4.88e-05	0.00451	CbGpPWpGaD
Pentamidine—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.85e-05	0.00448	CbGpPWpGaD
Pentamidine—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.78e-05	0.00442	CbGpPWpGaD
Pentamidine—S100B—Immune System—DCTN1—amyotrophic lateral sclerosis	4.75e-05	0.00439	CbGpPWpGaD
Pentamidine—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	4.74e-05	0.00438	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CASP9—amyotrophic lateral sclerosis	4.65e-05	0.0043	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—VAPB—amyotrophic lateral sclerosis	4.57e-05	0.00422	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—TPK1—amyotrophic lateral sclerosis	4.57e-05	0.00422	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.32e-05	0.004	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.26e-05	0.00394	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—VAPA—amyotrophic lateral sclerosis	4.18e-05	0.00386	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.07e-05	0.00376	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	3.98e-05	0.00368	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.98e-05	0.00368	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.88e-05	0.00359	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.77e-05	0.00348	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.73e-05	0.00345	CbGpPWpGaD
Pentamidine—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.72e-05	0.00344	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.72e-05	0.00344	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—FIG4—amyotrophic lateral sclerosis	3.65e-05	0.00337	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.54e-05	0.00327	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	3.52e-05	0.00325	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.46e-05	0.0032	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.41e-05	0.00315	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.37e-05	0.00311	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.36e-05	0.0031	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.33e-05	0.00308	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—C3—amyotrophic lateral sclerosis	3.31e-05	0.00306	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—DAO—amyotrophic lateral sclerosis	3.3e-05	0.00305	CbGpPWpGaD
Pentamidine—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.29e-05	0.00304	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.25e-05	0.00301	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.25e-05	0.00301	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.17e-05	0.00293	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.05e-05	0.00282	CbGpPWpGaD
Pentamidine—S100B—Immune System—SQSTM1—amyotrophic lateral sclerosis	3.03e-05	0.0028	CbGpPWpGaD
Pentamidine—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.02e-05	0.00279	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.98e-05	0.00276	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.89e-05	0.00267	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.85e-05	0.00264	CbGpPWpGaD
Pentamidine—S100B—Immune System—ATF1—amyotrophic lateral sclerosis	2.85e-05	0.00263	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.83e-05	0.00262	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.77e-05	0.00256	CbGpPWpGaD
Pentamidine—S100B—Immune System—CASP9—amyotrophic lateral sclerosis	2.71e-05	0.0025	CbGpPWpGaD
Pentamidine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.69e-05	0.00249	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.66e-05	0.00246	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.6e-05	0.0024	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	2.59e-05	0.0024	CbGpPWpGaD
Pentamidine—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	2.58e-05	0.00238	CbGpPWpGaD
Pentamidine—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.5e-05	0.00231	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PLB1—amyotrophic lateral sclerosis	2.5e-05	0.00231	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.47e-05	0.00228	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.37e-05	0.00219	CbGpPWpGaD
Pentamidine—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.37e-05	0.00219	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.33e-05	0.00216	CbGpPWpGaD
Pentamidine—S100B—Immune System—ERBB4—amyotrophic lateral sclerosis	2.32e-05	0.00214	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GSR—amyotrophic lateral sclerosis	2.31e-05	0.00213	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	2.24e-05	0.00207	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.23e-05	0.00206	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.21e-05	0.00204	CbGpPWpGaD
Pentamidine—S100B—Immune System—CD40LG—amyotrophic lateral sclerosis	2.18e-05	0.00202	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.17e-05	0.002	CbGpPWpGaD
Pentamidine—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.14e-05	0.00198	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.1e-05	0.00194	CbGpPWpGaD
Pentamidine—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.1e-05	0.00194	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.07e-05	0.00192	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.04e-05	0.00189	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.96e-05	0.00181	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.94e-05	0.00179	CbGpPWpGaD
Pentamidine—S100B—Immune System—C3—amyotrophic lateral sclerosis	1.93e-05	0.00178	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	1.92e-05	0.00177	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	1.92e-05	0.00177	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.91e-05	0.00176	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CHAT—amyotrophic lateral sclerosis	1.9e-05	0.00175	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.84e-05	0.0017	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.82e-05	0.00169	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.81e-05	0.00168	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.81e-05	0.00168	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.78e-05	0.00165	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	1.77e-05	0.00163	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.76e-05	0.00162	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	1.75e-05	0.00162	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.75e-05	0.00162	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.73e-05	0.0016	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.69e-05	0.00156	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	1.66e-05	0.00154	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	1.66e-05	0.00154	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.66e-05	0.00153	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.63e-05	0.00151	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.55e-05	0.00143	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.54e-05	0.00142	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	1.53e-05	0.00142	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	1.52e-05	0.0014	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.51e-05	0.00139	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.5e-05	0.00139	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.49e-05	0.00137	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	1.48e-05	0.00137	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	1.48e-05	0.00137	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.45e-05	0.00134	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.42e-05	0.00131	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.41e-05	0.00131	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.41e-05	0.0013	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.39e-05	0.00128	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.38e-05	0.00128	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	1.36e-05	0.00126	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	1.36e-05	0.00126	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.36e-05	0.00125	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.33e-05	0.00123	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.31e-05	0.00121	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.26e-05	0.00117	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.25e-05	0.00115	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.25e-05	0.00115	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.2e-05	0.00111	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.19e-05	0.0011	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.19e-05	0.0011	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.16e-05	0.00108	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.16e-05	0.00107	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.16e-05	0.00107	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.16e-05	0.00107	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.16e-05	0.00107	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.15e-05	0.00106	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.09e-05	0.00101	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.08e-05	0.000996	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.07e-05	0.000991	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.06e-05	0.000977	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.05e-05	0.000971	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.02e-05	0.000942	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.93e-06	0.000918	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	9.86e-06	0.000912	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.83e-06	0.000908	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	9.7e-06	0.000897	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.58e-06	0.000886	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.37e-06	0.000866	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	9.24e-06	0.000854	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	9.16e-06	0.000847	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	9.1e-06	0.000841	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	8.92e-06	0.000824	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	8.92e-06	0.000824	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	8.4e-06	0.000777	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	8.35e-06	0.000772	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.35e-06	0.000771	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.16e-06	0.000754	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	8.13e-06	0.000751	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	7.97e-06	0.000736	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—APOE—amyotrophic lateral sclerosis	7.71e-06	0.000712	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.65e-06	0.000707	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.58e-06	0.000701	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.53e-06	0.000696	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	7.5e-06	0.000693	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	7.47e-06	0.000691	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.38e-06	0.000682	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.13e-06	0.000659	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.97e-06	0.000644	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	6.9e-06	0.000638	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	6.9e-06	0.000638	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.87e-06	0.000635	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.83e-06	0.000631	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	6.45e-06	0.000596	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.33e-06	0.000585	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.3e-06	0.000582	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.26e-06	0.000579	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	6.16e-06	0.000569	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	5.84e-06	0.00054	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	5.66e-06	0.000524	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.62e-06	0.000519	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.32e-06	0.000492	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.28e-06	0.000488	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.89e-06	0.000452	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.8e-06	0.000444	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.73e-06	0.000437	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.71e-06	0.000435	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.51e-06	0.000417	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.38e-06	0.000405	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.31e-06	0.000399	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.28e-06	0.000396	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.04e-06	0.000374	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.93e-06	0.000364	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.85e-06	0.000356	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.72e-06	0.000344	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.71e-06	0.000343	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.7e-06	0.000342	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.41e-06	0.000315	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.31e-06	0.000306	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	3.24e-06	0.000299	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.06e-06	0.000283	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.04e-06	0.000281	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.04e-06	0.000281	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3e-06	0.000277	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	2.8e-06	0.000259	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.8e-06	0.000259	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.58e-06	0.000238	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	2.5e-06	0.000231	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.37e-06	0.000219	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.3e-06	0.000213	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.22e-06	0.000205	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.1e-06	0.000194	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.99e-06	0.000184	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.95e-06	0.00018	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.92e-06	0.000178	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.83e-06	0.000169	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.71e-06	0.000158	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.58e-06	0.000146	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.5e-06	0.000139	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.34e-06	0.000123	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.03e-06	9.53e-05	CbGpPWpGaD
